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Background. Congenital heart diseases often involve chronic pressure overload of the right ventricle (RV) which is a major
cause of RV dysfunction. Pulmonary artery (PA) banding has been used to produce animal models of RV dysfunction. We have
devised a new and easier method of constricting the PA and compared it directly with the partial ligation method. Methods.
Eight-week-old male Sprague-Dawley rats (240–260 g) were divided into three groups: sham operation, partial pulmonary
artery ligation (PAL) procedure, and pulmonary artery half-closed clip (PAC) procedure. RV function and remodeling were
determined by echocardiography and histomorphometry. Results. Surgical mortality was significantly lower in the PAC group
while echocardiography revealed significantly more signs of RV dysfunction. At the 8th week after surgery RV fibrosis rate was
significantly higher in the PAC group. Conclusions. This procedure of pulmonary artery banding in rats is easier and more efficient
than partial ligation.
1. Introduction
The exact prevalence of pediatric heart failure is largely
unknown but it is increasing. Recent advances in diagnostic
methods, new surgical techniques, and improved periopera-
tive management have contributed to an increased survival
for patients with complex congenital heart disease who today
often survive into adulthood [1].
Even after successful repair, however, right ventricle (RV)
pressure overload remains in some patients and eventually
impairs RV function and influences long-term mortality and
morbidity [2–4].
Although compensated hypertrophy develops initially,
ultimately RV failure will occur. The mechanisms underlying
the progression from compensated to decompensated RV
hypertrophy have not been well defined [5].
Clinically, the relationship between progressive fibrosis
and RV function must be addressed [6, 7]. But studies of the
mechanisms underlying the transition from a compensated
state of hypertrophy to a decompensated state are difficult
in patients, because invasive data cannot be easily obtained.
For this purpose, animal models may be beneficial. Small
experimental animals, such as rats, are widely used in cardio-
vascular research since they can provide a range of disease
models, including cardiac hypertrophy and failure. A major
advantage of these disease models is that cardiac material can
be easily sampled to study the pathology of the disease in
question.
The partial pulmonary artery ligation procedure has
been widely used to produce right heart failure caused
by pressure overload, but this procedure might have
important drawbacks including a high surgical mortality
caused by bleeding, sudden cardiac arrest, or pulmonary
thrombus.
Pressure overload may also be induced using half-closed
paper clips easily applied with a stopper. We could adjust
the closing size by moving the stopper. The objective of this
study was to establish rats model of RV failure using the
pulmonary artery half-closed clip procedure comparing with
partial ligation procedure.
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Figure 1: The PAC method. (a) Left thoracotomy was performed in the right semilateral decubitus position. (b) mPA was exposed through
the left thoracotomy. ((c), (d)) Placement of a half-closed clip around mPA.
2. Materials and Methods
2.1. Animal Care. All experimental procedures and protocols
used in this investigation were reviewed and approved by
the institutional animal care and use committee and were in
accordance with the National Institutes of Health “guide for
the care and use of laboratory animals” (National Institutes of
Health publication number 85-23, revised 1996).
2.2. Animal Model. A rat model of the pulmonary artery
banding (PAB) was established to create chronic RV pressure
overload. Eight-week-old male Sprague-Dawley rats (240–
260 g) were anesthetized with intraperitoneal pentobarbital
(50mg/kg body weight) and xylazine (5mg/kg) and venti-
lated with 100% O
2
by using a volume controlled respirator
(2mL, 60 cycles/min). A left thoracotomy was performed at
the fourth intercostal space, and the main pulmonary artery
(mPA) was carefully exposed (Figure 1).
2.2.1. Partial Pulmonary Artery Ligation Model (PAL) (𝑛 =
28). A 7-0 prolene suture was tied tightly around an 18-gauge
needle alongside the mPA. After subsequent rapid removal
of the needle, a fixed constricted opening was created in the
lumen equal to the diameter of the needle [5, 8, 9].
2.2.2. Half-Closed Clip Model (PAC) (𝑛 = 28). A small clip
(LT100 ETHICON) was half-closed around the mPA using
a clip applier (LX107 ETHICON) with a stopper (Figure 1).
The blood flow through the mPA was restricted to equal the
inner segment of the half-closed clip.We selected type (B) clip
because this inner size was almost equal to outer size of a 18G
needle (Figure 2).
Thereafter, the thorax was closed in layers, and the
ventilator setting was changed (90 cycles/min) for half an
hour to reduce the respiratory load.
2.2.3. Sham Operation (𝑛 = 12). A left thoracotomy was
performed at the fourth intercostal space, and the mPA was
carefully exposed. The thorax was closed in layers, and the
ventilator setting was changed (90 cyclesmin−1) for half an
hour to reduce the respiratory load.
2.3. Echocardiographic Measurements. Echocardiograms
were recorded on the preoperative day and on the 4th week
and 8th week after the procedure.The rats were anaesthetized
for echos (pentobarbital 50mg kg−1 body weight) but were
breathing spontaneously and were positioned on their left
side.
Measuring echocardiograms, the dose of anesthetics was
reduced to 50% only on the day when a rat had developed
clinical signs, loss of activity, body edema, and pleural
effusion, of RV failure. Transthoracic 2-dimensional, M-
mode (according to the standards of the American Society
of Echocardiography) and Doppler imaging were performed
with a 6.5MHz transducer (Xario TOSHIBA, JAPAN).
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Figure 2: (a) Half-closed clips (A), (B), and (C) with different placed stopper. (b) Size of inner area of clips (A), (B), and (C), respectively,
comparing with 18G needle outer size. In this paper, we used (B) type for the PAC method.
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Figure 3: Schemata of echocardiograms measurements. (a) The parasternal long-axis view. (b) Parasternal short-axis view. (c) The apical
four-chamber view.
Figure 3 showed schemata of the measurements of
echocardiograms, respectively.
The RV morphology was assessed as RV free wall thick-
ness (RVWT) andRV end-diastolic diameter (RVDd) andRV
outflow tract dimension (RVOTD). RVWT was measured by
M-mode either in the 2-dimensional parasternal short-axis
view below the tricuspid valve or in the parasternal long-axis
view, depending on the quality of RV free wall visualization.
RVDd was measured as the maximal distance from the RV
free wall to the septum from the apical four-chamber view.
RVOTD and aortic dimension (AoD) were measured at
the aortic valve level in the short-axis view. The ratio of
RVOTD to AoD (RVOTD/AoD) was calculated as represen-
tative of RV dilatation. The position of the transducer was
aligned to visualize the RV apex.
The maximal RV cavity size preceding the frame with
the onset of systolic closure of tricuspid valve leaflets was
used to measure RVDd. To assess RV function, the tri-
cuspid annular plane systolic excursion (TAPSE) of the
lateral portion of the tricuspid annular plane was measured
by the base-to-apex shortening during systole. This was
recorded in the M-mode format under two-dimensional
echocardiographic guidance from the apical four-chamber
view.
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Furthermore, PA velocity (PAv) was recorded at the
aortic valve level in the short-axis view. This was used as an
echocardiographic indicator of RV pressure overload [10, 11].
The left ventricle (LV) M-mode echocardiograms were
recorded to evaluate LV function, as previously described. LV
end-diastolic dimension (LVDd), LV end-systolic dimension
(LVDs), interventricular septal wall thickness (IVST), and
LV posterior wall thickness (LVPW) were measured at the
papillary muscles level, and LV fractional shortening (LVFS)
was calculated as follows:
LVFS = [(LVDd − LVDs)
LVDd
] × 100 (%) . (1)
2.4. Histopathological Analysis. In the PAL group, the
remaining 4 rats were killed 4 weeks after surgery and all
the remaining rats (𝑛 = 8) were killed 8 weeks after surgery.
In the PAC group, 4 rats were killed 4 weeks after surgery
and all the remaining rats (𝑛 = 6) were killed 8 weeks after
surgery. In the shamgroup, 6 ratswere killed 4 or 8weeks after
surgery. The hearts were quickly removed, and the ventricles
were dissected free of atrial tissue and large blood vessels.The
right ventricle was carefully separated from the left ventricle
and interventricular septum (IVS). The fresh ventricular
tissues were immediately blotted dry and weighted separately
to determine the degree of RV hypertrophy based on 2
parameters: RV wall weight/body weight (RV/BW) and RV
wall weight/LV and IVS wall weight (RV/LV + IVS).
Tissue specimens for pathological analysis were obtained
from whole hearts in cross sections, cut into 5mm thick
sections, and stained with hematoxylin and eosin for mor-
phologic analysis, including measurement of the short-axis
dimension of the RVmyocardial cell and Masson’s trichrome
staining to determine the amount of interstitial and myocar-
dial fibrosis. Digital images of cross sections were taken by
a CCD camera (OLYMPUS DP-72) with a light microscope
(OLYMPUS SZX12).The number of pixels of the blue-stained
collagen area was calculated with Adobe Photoshop CS5 soft
and then divided by the total number of pixels in the RV wall
per slide, analyzed, and averaged.
2.5. Statistical Analysis. All data were expressed as mean
± SEM and range. Student’s unpaired 𝑡-test or analysis of
variance for parametric values was used to compare group
means. Probability of 0.05 or less was considered to be
statistically significant.
3. Results
3.1. Procedure. Surgical procedure time was defined as the
interval from starting to incise the skin to skin closure. The
surgical procedure timewas 27.6 ± 1.4min for PAL and 17.3 ±
2.1min for PAC (𝑝 < 0.01). For the PAL procedure, 5 major
hemorrhages occurred during trimming the mPA compared
to only one major hemorrhage for the PAC procedure.
To evaluate the two procedures for RV pressure overload
damage, we recorded the postsurgery recovery time. This
was defined as the interval from time of extubation until the
animal was fully conscious and walking freely. The recovery
time was 30.4 ± 5.3min for the sham procedure and 33.5 ±
5.2min for PACwhich was significantly shorter than the PAL
procedure which was 64.9 ± 7.3min.
3.2. Surgical Risk. Sixty-eight rats underwent PAL (𝑛 = 28)
or PAC (𝑛 = 28) or sham (𝑛 = 12) in the surgical risk study.
During the perisurgical period, which was the time from the
beginning of surgery to 6 hours after surgery, 1 rat in the PAC
group out of 28 died due to bleeding (3.6%).
In contrast, 7 of 28 perisurgical deaths were seen in the
PAL group (25%). Of those 7 rats, 1 died from an intubation
accident, 2 died from bleeding, 2 died from pneumothorax,
and 2 died from sudden cardiac arrest. All of the animals in
the sham group survived regardless of the surgical procedure.
After the perisurgical period, there were 3 and 12 deaths in
the PAL and PAC groups, respectively. The most common
reasons for post-PAB death in both groups were pleural
and/or pericardial effusion (pleural effusion: 66.7% in PAL
and 83.3% in PAC, pericardial effusion: 33.3% in PAL and
41.7% in PAC) occurring between weeks 4 and 8 after surgery.
Some of the rats died of unknown causes although we
assumed these were due to either cardiac arrhythmia or
heart failure as autopsy of these rats showed no blood in the
thoracic cavity.
3.3. Echocardiographic Study. Table 1 shows the trend for
LVDd and AoD to decrease but LV contractility (LVFS)
showed no significant difference. Both PAL and PAC groups
showed a significantly increased pulsed Doppler Peak PAv,
RVOTD, RVDd, and RVWT. In the PAC group, PAv and
RVOTD tended to increase more significantly than in the
PAL group. The dilatation of the RV associated with the
RVDd/LVDd ratio and the RVOTD/AoD ratio. In the PAC
group, the RVDd/LVDd ratio was increased and became
significantly greater than in the sham and PAL group. The
RVOTD/AoD ratio was about 1.0 throughout the observation
in the sham group. In contrast, the ratio increased progres-
sively in the PAL and PAC groups, especially in the PAC
group.
The signs of RV failure associated with TAPSE were more
severe in the PAC group than in the PAL group. The signs
of moderate or severe tricuspid regurgitation (TR) or pleural
effusion or IVC dilation were detected in the PAC group 5
weeks after the PAC procedure, but we could seldom detect
these signs in the PAL group throughout the observation
period (PAC versus PAL: moderate or more TR 21/27 (77.8%)
versus 3/21 (14.3%), pleural effusion 18/27 (66.7%) versus 2/21
(10.0%), and IVC dilation 20/27 (74.1%) versus 0/21 (0%)).
Furthermore, the standard deviation in the PAC group
was greater than the PAL group. In other words, the data of
the PAL group variedmorewidely than that of the PACgroup.
More stable data might be obtained with the PAC procedure.
3.4. Morphometric and Histological Analysis
3.4.1. RV Hypertrophy. A weight analysis showed the heart
weight/BW, RV/BW, and RV/(LV + IVS) weight ratios in the
PAC and PAL groups to be similar and significantly higher
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Table 1: Ultrasound findings in the sham rats, at 4th or 8th week after the PAB procedure.
Preoperative day 4th week 8th week
Sham PAL PAC Sham PAL PAC Sham PAL PAC
𝑛 12 28 28 12 16 22 6 8 6
LVDd (mm) 4.66 ± 0.43 4.75 ± 0.43 4.67 ± 0.39 5.36 ± 0.36 5.10 ± 0.42 5.07 ± 0.51 5.78 ± 0.19 5.40 ± 0.29 5.42 ± 0.38
LVDs (mm) 2.10 ± 0.5 2.15 ± 0.47 2.06 ± 0.47 2.51 ± 0.38 2.88 ± 0.58 2.55 ± 0.31 2.90 ± 0.52 2.38 ± 0.38 2.68 ± 0.45
IVST (mm) 1.06 ± 0.27 1.11 ± 0.29 1.14 ± 0.31 1.57 ± 0.10 1.56 ± 0.16 1.65 ± 0.27 1.93 ± 0.21 1.90 ± 0.10 2.13 ± 0.22
PWT (mm) 1.01 ± 0.24 1.05 ± 0.27 1.04 ± 0.27 1.71 ± 0.29 1.51 ± 0.08 1.62 ± 0.20 2.23 ± 0.22 2.04 ± 0.09 1.97 ± 0.14
FS (%) 55.17 ± 8.74 55.02 ± 8.17 56.15 ± 8.68 53.27 ± 4.42 42.81 ± 15.09 49.78 ± 4.02 49.62 ± 10.14 56.07 ± 5.10 50.64 ± 5.51
RVDd (mm) 2.46 ± 0.31 2.49 ± 0.29 2.49 ± 0.26 2.43 ± 0.28 5.48 ± 1.47⋆ 6.26 ± 1.28⋆ 2.80 ± 0.58 5.26 ± 0.96⋆ 6.95 ± 0.63⋆
RVWT (mm) 0.63 ± 0.19 0.65 ± 0.18 0.70 ± 0.17 0.54 ± 0.08 1.25 ± 0.11⋆ 1.41 ± 0.28⋆ 0.98 ± 0.1 1.72 ± 0.15⋆ 1.80 ± 0.43⋆
TAPSE (mm) 2.71 ± 0.22 2.69 ± 0.21 2.69 ± 0.23 2.53 ± 0.14 2.40 ± 0.11 1.67 ± 0.20⋆$ 2.58 ± 0.1 2.32 ± 0.20 1.42 ± 0.25⋆$
HR (bpm) 438 ± 43 441 ± 39 455 ± 24 447 ± 21 436 ± 26 422 ± 31 451 ± 22 419 ± 20 411 ± 30
Peak PAV (m/s) 0.76 ± 0.11 0.73 ± 0.12 0.71 ± 0.12 0.97 ± 0.14 2.93 ± 0.54⋆ 3.91 ± 0.38⋆$ 1.05 ± 0.13 3.28 ± 0.37⋆ 4.03 ± 0.27⋆$
RVOTD (mm) 1.99 ± 0.20 2.00 ± 0.24 1.97 ± 0.25 2.64 ± 0.17 2.98 ± 0.37# 3.22 ± 0.50⋆ 2.20 ± 0.16 2.78 ± 0.37# 3.62 ± 0.16⋆$
AoD (mm) 2.23 ± 0.25 2.25 ± 0.23 2.30 ± 0.21 2.80 ± 0.18 2.65 ± 0.11 2.55 ± 0.22# 2.78 ± 0.05 2.44 ± 0.35 2.65 ± 0.10
RVDd/LVDd 0.53 ± 0.08 0.53 ± 0.07 0.53 ± 0.05 0.46 ± 0.07 1.08 ± 0.28⋆ 1.25 ± 0.32⋆ 0.48 ± 0.09 0.971 ± 0.15⋆ 1.28 ± 0.08⋆$
RVOTD/AoD 0.90 ± 0.16 0.90 ± 0.16 0.86 ± 0.15 0.95 ± 0.07 1.12 ± 0.14# 1.27 ± 0.20⋆ 0.79 ± 0.07 1.157 ± 0.21# 1.37 ± 0.10⋆†
RVPW/LVPW 0.65 ± 0.23 0.65 ± 0.21 0.69 ± 0.20 0.32 ± 0.05 0.83 ± 0.08⋆ 0.87 ± 0.15⋆ 0.44 ± 0.06 0.844 ± 0.07⋆ 0.92 ± 0.24⋆
𝑛, number of rats. #: 𝑝 < 0.05 versus sham, ⋆: 𝑝 < 0.01 versus sham, †: 𝑝 < 0.05 versus PAL, and $: 𝑝 < 0.01 versus PAL.
Table 2: Weight analysis at the 4th and 8th week after the PAB
procedure.
(a) Weight analysis at the 4th week after the procedure
BW HW/BW RV/BW RV/(LV + IVS)
(g) ratio (mg/g) ratio (mg/g) ratio
Sham 435 ± 39 3.57 ± 0.16 0.56 ± 0.07 0.21 ± 0.02
PAL 403 ± 21 4.65 ± 0.17⋆ 1.40 ± 0.13⋆ 0.50 ± 0.04⋆
PAC 398 ± 33 4.88 ± 0.17⋆ 1.39 ± 0.03⋆ 0.49 ± 0.04⋆
(b) Weight analysis at the 8th week after the procedure
BW HW/BW RV/BW RV/(LV + IVS)
(g) ratio (mg/g) ratio (mg/g) ratio
Sham 508 ± 41 3.30 ± 0.23 0.48 ± 0.04 0.21 ± 0.01
PAL 505 ± 47 4.34 ± 0.30⋆ 1.27 ± 0.12⋆ 0.54 ± 0.02⋆
PAC 450 ± 50 4.81 ± 0.32⋆ 1.40 ± 0.07⋆ 0.58 ± 0.03⋆
There was no significant difference between the PAL and PAC groups.
BW: body weight at the sacrifice time, HW: heart weight, and ⋆: 𝑝 < 0.05
versus sham.
than in the sham group (Table 2). Whole heart findings
revealed a thickened RVwall, with an enlarged cavity, and the
IVS shifted toward the left side in the PAC and PAL groups
(Figure 5). Myocardial cell size in the PAC and PAL groups
was similar and significantly higher than in the sham group
(4thweek: shamversus PAL versus PAC: 13.7±1.64 𝜇mversus
21.3 ± 3.47 𝜇m versus 22.8 ± 2.38 𝜇m, 8th week: sham versus
PAL versus PAC: 14.3 ± 1.40 𝜇m versus 34.7 ± 7.22 𝜇m versus
35.1 ± 8.19 𝜇m) (Table 1, Figure 4).
3.4.2. Fibrosis. Masson’s trichrome staining showed fibrosis
in the RV free walls of the sham, PAL, and PAC groups
(Figure 6). At the 4th week, the percentage of fibrosis in the
PAL and PAC groups was similar and significantly higher
than in the sham group (sham versus PAL versus PAC: 0.49 ±
0.06% versus 3.12±1.09% versus 4.68±1.63%) (Figure 6(b)).
But at 8 weeks, the percentage fibrosis in the PAC group was
significantly higher than in the sham and PAL groups (sham
versus PAL versus PAC: 1.51 ± 0.86% versus 9.73 ± 6.05%
versus 29.2 ± 6.13%) (Figure 6(b)).
4. Discussion
Definition of heart failure was challenging because there
were neither objective cutoff values of cardiac or ventricular
dysfunction nor changes in pressure, dimension, or volume
that could be reliably used to identify patients with heart
failure. According toTheEuropean Society ofCardiology task
force for the diagnosis and treatment of heart failure, both
symptoms at rest or during exertion and objective evidence
of cardiac dysfunction at rest should be present to diagnose
heart failure [12].
In animal models, however, heart failure symptoms like
fatigue or breathlessness are difficult to detect and quantify.
Then evaluation of the models depends on objective findings
such as reduced cardiac output, increased filling pressure, and
progressive fibrosis [6, 7, 13]. In addition, the valuable signs
of progressive heart failure are pericardial or pleural effusion
[14]. In this paper, we demonstrated right heart failure by the
objective findings of cardiac dysfunction.
Most attention is given to LV function, whereas RV
function and disease have seldom been focused on. It is
an established fact that there is a relationship between LV
and RV function. Impairment of the RV might influence LV
function [15, 16]. RV function is one independent predictor
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Figure 4: Photomicrographs of hematoxylin and eosin-stained sections showed significantly hypertrophied ventricular myocytes in the PAL
and PAC groups. Scale bar: 20𝜇m. ∗𝑝 < 0.01.
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Figure 5: Macroscopic photographs of Masson’s trichrome-stained cross sections showed RV wall thickening, cavity enlarging, and the
interventricular septum shifting toward the left side in the PAL and PAC groups. Scale bar: 2mm.
of mortality and the development of heart failure in patients
with LV dysfunction [17]. Five to ten percent of patients
with advanced chronic obstructive pulmonary disease may
suffer from severe pulmonary hypertension and present
with a progressively downhill clinical course because of RV
dysfunction [18]. Not only in the view point of congenital
heart disease, well-established animal models of RV function
may be necessary for further investigation of RV function
and pathology. Some animal models of RV dysfunction exist
(monocrotaline treatment, partial ligation method) [5, 8–
10, 19]. Monocrotaline treatment has been used to induce
pulmonary hypertension resulting in RV hypertrophy and
eventually heart failure [20, 21]. Monocrotaline treatment
might have disadvantages in the form of disease manifesta-
tions not usually associated with human heart failure and
changes in hormones such as endothelin [21, 22]. PAB does
not have such side effects and is a promising procedure
for inducing symptomatic RV dysfunction. PAL procedure
has been used in several hypertrophy experiments; however,
slippage of the band and the obvious difficulties ensuring
the same degree of constriction among the banded animals
when using a surgical nylon (usually prolene) led us to believe
that banding with tantalum clips would be a more reliable
procedure to create PAB model. In another PAB study using
surgical nylon thread, PAL procedure, about 25% of the
banded rats showed no hypertrophy [23], suggesting that this
was a less reliableway. Also in this study, in the PAL group, the
data had greater variance than in the PAC group. In addition,
the objective findings of RV dysfunction were present less in
the PAL group.
To the best of our knowledge this is the first reported
evaluation of a newly devised means of stressing the right
ventricle—the half-closed clip procedure—and its compari-
sonwith the pulmonary artery banding procedure. Using this
new technique we could produce a right heart failure model
in significantly less time and with much faster recovery and
fewer surgical deaths than the PAL procedure. Most impor-
tantly, this novel procedure more fully developed subsequent
myocardial damage and postsurgery cardiac dysfunction
than did the PAL procedure. Furthermore, if we adjust the
position of the stopper, we can produce different PABmodels
using this procedure.
A recent study in rats who underwent banding of the
mPA by the existing partial ligation procedure showed that
pressure overload alone was insufficient to explain right heart
failure; the rats showed no effect on cardiac output or fibrosis
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Figure 6: (a) Representative photomicrographs of Masson’s trichrome-stained RV free wall (scale bar: 500 𝜇m). (b) Evaluation of fibrosis
area for RV free wall. ∗𝑝 < 0.05, ∗∗𝑝 < 0.01.
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[24]. Using the PAC procedure, however, we could produce
RV dysfunction models that represent not only RV cavity
dilation and RV hypertrophy but also moderate or greater
tricuspid regurgitation or pleural and/or pericardial effusion.
Hardziyenka and colleagues reported LV atrophy in
pulmonary hypertension [25]. However, we could not detect
significant left-sided effects, but we could find a trend towards
LV atrophy (Table 1 LVPWT, PAC versus sham, 𝑝 = 0.051).
5. Conclusion
This study demonstrated that the application of a tantalum
half-closed clip around the pulmonary artery induced right
ventricle dysfunction in a reproducible manner. This model
should prove valuable in the investigation and treatment of
right heart failure caused by pressure overload.
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
References
[1] M. S. Patel and B. E. Kogon, “Care of the adult congenital heart
disease patient in the United States: a summary of the current
system,” Pediatric Cardiology, vol. 31, no. 4, pp. 511–514, 2010.
[2] A. P. Bolger, A. J. S. Coats, and M. A. Gatzoulis, “Congenital
heart disease: the original heart failure syndrome,” European
Heart Journal, vol. 24, no. 10, pp. 970–976, 2003.
[3] J. G. Murphy, B. J. Gersh, D. D. Mair et al., “Long-term outcome
in patients undergoing surgical repair of tetralogy of Fallot,”The
New England Journal of Medicine, vol. 329, no. 9, pp. 593–599,
1993.
[4] M. A. Gatzoulis, S. Balaji, S. A. Webber et al., “Risk factors
for arrhythmia and sudden cardiac death late after repair of
tetralogy of Fallot: a multicentre study,”The Lancet, vol. 356, no.
9234, pp. 975–981, 2000.
[5] M. J. Faber, M. Dalinghaus, I. M. Lankhuizen et al., “Right
and left ventricular function after chronic pulmonary artery
banding in rats assessed with biventricular pressure-volume
loops,” American Journal of Physiology—Heart and Circulatory
Physiology, vol. 291, no. 4, pp. H1580–H1586, 2006.
[6] S. V. Babu-Narayan, P. J. Kilner,W. Li et al., “Ventricular fibrosis
suggested by cardiovascular magnetic resonance in adults with
repaired tetralogy of Fallot and its relationship to adverse
markers of clinical outcome,”Circulation, vol. 113, no. 3, pp. 405–
413, 2006.
[7] U. K. Chowdhury, S. Sathia, R. Ray, R. Singh, K. K. Pradeep, and
P. Venugopal, “Histopathology of the right ventricular outflow
tract and its relationship to clinical outcomes and arrhythmias
in patients with tetralogy of Fallot,”The Journal of Thoracic and
Cardiovascular Surgery, vol. 132, no. 2, pp. 270.e4–277.e4, 2006.
[8] T. Hoashi, G. Matsumiya, S. Miyagawa et al., “Skeletal myoblast
sheet transplantation improves the diastolic function of a
pressure-overloaded right heart,” Journal of Thoracic and Car-
diovascular Surgery, vol. 138, no. 2, pp. 460–467, 2009.
[9] M. U. Braun, P. Szalai, R. H. Strasser, and M. M. Borst, “Right
ventricular hypertrophy and apoptosis after pulmonary artery
banding: regulation of PKC isozymes,”Cardiovascular Research,
vol. 59, no. 3, pp. 658–667, 2003.
[10] J. E. Jones, L. Mendes, M. A. Rudd, G. Russo, J. Loscalzo,
and Y.-Y. Zhang, “Serial noninvasive assessment of progressive
pulmonary hypertension in a rat model,” American Journal of
Physiology—Heart andCirculatory Physiology, vol. 283, no. 1, pp.
H364–H371, 2002.
[11] R.Martin-Duran,M. Larman,A. Trugeda et al., “Comparison of
Doppler-determined elevated pulmonary arterial pressure with
pressure measured at cardiac catheterization,” The American
Journal of Cardiology, vol. 57, no. 10, pp. 859–863, 1986.
[12] K. Swedberg, J. Cleland, H. Dargie et al., “Guidelines for the
diagnosis and treatment of chronic heart failure: executive
summary (update 2005),” European Heart Journal, vol. 26, no.
11, pp. 1115–1140, 2005.
[13] J. R. R. Heyen, E. R. Blasi, K. Nikula et al., “Structural, func-
tional, and molecular characterization of the SHHF model
of heart failure,” American Journal of Physiology—Heart and
Circulatory Physiology, vol. 283, no. 5, pp. H1775–H1784, 2002.
[14] H. Shigematsu, Y. Hirooka, K. Eshima, M. Shihara, T. Tagawa,
and A. Takeshita, “Endogenous angiotensin II in the NTS
contributes to sympathetic activation in rats with aortocaval
shunt,” American Journal of Physiology—Regulatory Integrative
and Comparative Physiology, vol. 280, no. 6, pp. R1665–R1673,
2001.
[15] C. M. Yu, J. E. Sanderson, S. Chan, L. Yeung, Y. T. Hung, and
K. S. Woo, “Right ventricular diastolic dysfunction in heart
failure,” Circulation, vol. 93, no. 8, pp. 1509–1514, 1996.
[16] M. F. Hill and P. K. Singal, “Right and left myocardial antiox-
idant responses during heart failure subsequent to myocardial
infarction,” Circulation, vol. 96, no. 7, pp. 2414–2420, 1997.
[17] L. A.M. Zornoff, H. Skali, M. A. Pfeffer et al., “Right ventricular
dysfunction and risk of heart failure andmortality aftermyocar-
dial infarction,” Journal of the American College of Cardiology,
vol. 39, no. 9, pp. 1450–1455, 2002.
[18] R. Naeije, “Pulmonary hypertension and right heart failure
in chronic obstructive pulmonary disease,” Proceedings of the
American Thoracic Society, vol. 2, pp. 20–22, 2005.
[19] Y. Kato,M. Iwase, H. Kanazawa et al., “Progressive development
of pulmonary hypertension leading to right ventricular hyper-
trophy assessed by echocardiography in rats,” Experimental
Animals, vol. 52, no. 4, pp. 285–294, 2003.
[20] L. Chen, X. T. Gan, J. V. Haist et al., “Attenuation of compen-
satory right ventricular hypertrophy and heart failure following
monocrotaline-induced pulmonary vascular injury by the Na+
−H+ exchange inhibitor cariporide,” Journal of Pharmacology
and Experimental Therapeutics, vol. 298, no. 2, pp. 469–476,
2001.
[21] S. A. Doggrell and L. Brown, “Rat models of hypertension,
cardiac hypertrophy and failure,” Cardiovascular Research, vol.
39, no. 1, pp. 89–105, 1998.
[22] T. Miyauchi, R. Yorikane, S. Sakai et al., “Contribution of
endogenous endothelin-1 to the progression of cardiopul-
monary alterations in rats with monocrotaline-induced pul-
monary hypertension,” Circulation Research, vol. 73, no. 5, pp.
887–897, 1993.
[23] R.H. LekanneDeprez,M. J. B. van denHoff, P. A. J. de Boer et al.,
“Changing patterns of gene expression in the pulmonary trunk-
banded rat heart,” Journal of Molecular and Cellular Cardiology,
vol. 30, no. 9, pp. 1877–1888, 1998.
10 BioMed Research International
[24] H. J. Bogaard, R. Natarajan, S. C. Henderson et al., “Chronic
pulmonary artery pressure elevation is insufficient to explain
right heart failure,” Circulation, vol. 120, no. 20, pp. 1951–1960,
2009.
[25] M.Hardziyenka,M. E. Campian,H. J. Reesink et al., “Right ven-
tricular failure following chronic pressure overload is associated
with reduction in left ventricular mass: evidence for atrophic
remodeling,” Journal of the American College of Cardiology, vol.
57, no. 8, pp. 921–928, 2011.
